Related Experiment Videos
Abnormal sleeping ventilatory pattern in infants of substance-abusing mothers
American Journal of Diseases of Children (1960)
|October 1, 1986
Summary
Infants born to substance-abusing mothers exhibit abnormal sleep breathing patterns, increasing their risk for sudden infant death syndrome (SIDS). These findings highlight potential links between maternal substance abuse and infant respiratory control issues.
Area of Science:
- Neonatal physiology
- Pediatric respiratory medicine
- Public health
Background:
- Infants exposed to opiates in utero show reduced ventilatory response to carbon dioxide.
- These infants have a significantly higher risk (5-10x) of sudden infant death syndrome (SIDS).
- Abnormalities in ventilatory control may manifest as irregular breathing patterns during sleep.
Purpose of the Study:
- To investigate sleeping ventilatory patterns in infants of substance-abusing mothers (ISAM).
- To compare pneumogram data between ISAM and control infants.
- To assess the relationship between abnormal sleep breathing and SIDS risk in ISAM.
Main Methods:
- Overnight pneumograms (respiratory and ECG monitoring) were recorded for 27 ISAM and 43 control infants.
- Pneumograms were analyzed for total sleep time, apnea duration, periodic breathing, and heart/respiratory rates.
- Infant groups were compared based on these quantitative sleep and respiratory parameters.
Main Results:
- ISAM infants demonstrated longer total sleep time and increased durations and frequency of apnea (≥6s).
- ISAM infants exhibited more periodic breathing, higher mean respiratory rates, and lower mean heart rates compared to controls.
- Abnormal pneumograms were found in 32% of ISAM versus 9.3% of control infants.
Conclusions:
- Infants of substance-abusing mothers display significantly abnormal sleeping ventilatory patterns.
- These abnormal patterns are a potential contributing factor to the elevated SIDS risk observed in this population.
- Findings underscore the importance of monitoring respiratory function in infants with prenatal substance exposure.